Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adu...
Published in CNS Oncology
Published in CNS Oncology
Published in Annals of Translational Medicine
Published in Cancer Cell International
Published in Oncotarget